Psychologists may prescribe psychotropic meds

Summary#

SB 844 would amend the Virginia Code and add a new article to its psychology chapter. It would let qualified, licensed clinical psychologists apply for approval to prescribe psychotropic medication under set limits; the bill’s apparent goal is to add this prescribing role within psychology practice. The bill is introduced and is not law. The supplied text ends partway through a section, so this summary covers only the provisions provided.

  • The Virginia Board of Psychology would license clinical prescribing psychologists who meet education, training, exam, insurance, certification, background-check, fee, and collaboration requirements.
  • A licensed clinical prescribing psychologist would need a written agreement with an approved collaborating provider. The agreement must set consultation, case-review, and emergency-care arrangements.
  • The bill would add these psychologists to existing Code provisions that name people authorized to prescribe or handle controlled substances. The visible text does not specify which controlled-substance schedules they could prescribe.
  • The bill would generally bar prescribing for patients under 17, age 65 or older, pregnant, or within 12 months after delivery. It includes some transition and pregnancy-related provisions, but the supplied text cuts off before those provisions are complete.
  • The bill would change the existing rule that psychology practice does not permit prescribing: it would add an exception for prescribing under the new article. The current Code was not supplied, so the full extent of changes to existing law could not be verified.

What it means for you#

  • Clinical psychologists: A clinical psychologist could seek this added authority, but would need the required postdoctoral training, at least 400 supervised clinical hours involving at least 100 patients, an approved exam, and a collaboration agreement, among other requirements.
  • Patients: The authority is tied to psychotropic medication and does not authorize independent medical practice. Psychologists could not prescribe for the listed age and pregnancy groups, subject to exceptions described in the incomplete text.
  • Collaborating providers: A physician, certain advanced practice registered nurses, or another Board-approved qualified prescriber could enter a written agreement. The agreement must be reviewed at least yearly and include consultation and case-review terms. It does not put the psychologist under the provider’s direction in the psychologist’s professional judgment.
  • Pharmacists and other prescribers: The bill would add clinical prescribing psychologists to existing prescription-related provisions. The supplied text does not fully show how their authority would apply to particular drugs or schedules.

Money#

The bill requires fees and professional liability insurance, but the supplied material gives no cost estimate.

  • Applicants would pay fees set by the Board and maintain insurance, but the amounts and insurance costs are not stated.
  • Applicants would need additional education, supervised training, and certification; the cost and availability of these requirements are not stated.
  • No public spending or staffing estimate is included in the supplied text.

What is unclear#

  • The supplied bill text stops during the pregnancy-related rules and does not include the rest of the bill. The title mentions a report, but the provided text does not show its requirements.
  • The visible text does not identify which drugs or controlled-substance schedules psychologists could prescribe.
  • It is unclear what standards the Board would use to approve other training programs, exams, or collaborating providers.
  • The bill does not state when its provisions would take effect.
  • The current Code text was not supplied, so the full changes to existing law could not be checked.

Case for#

  • The bill appears intended to allow some clinical psychologists to prescribe psychotropic medication after substantial additional education, supervised practice, and examination.
  • A possible argument for the bill is that its required collaboration agreement, case reviews, and consultation rules could connect prescribing to medical expertise without making the collaborating provider direct the psychologist’s clinical judgment.
  • The patient exclusions and referral requirements appear designed to set limits for some situations the bill treats as needing medical involvement.

Case against#

  • One concern is that the collaboration agreement does not subject the psychologist’s prescribing judgment to the collaborating provider’s direction, while the visible text does not explain how compliance would be checked beyond case reviews and Board oversight.
  • The age and pregnancy restrictions, including a required transfer of care for some older patients, could complicate continuity of medication care; the supplied text does not show all the exceptions or transition rules.
  • The bill does not state which drugs or schedules are allowed, or include cost estimates for training, insurance, or implementation.